about
Lifespan extension and cancer prevention in HER-2/neu transgenic mice treated with low intermittent doses of rapamycinMetformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis.Succinate and its G-protein-coupled receptor stimulates osteoclastogenesis.From rapalogs to anti-aging formula.Metformin limits the adipocyte tumor-promoting effect on ovarian cancer.TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists.Glipizide, an antidiabetic drug, suppresses tumor growth and metastasis by inhibiting angiogenesis.Comparison of rapamycin schedules in mice on high-fat diet.Koschei the immortal and anti-aging drugsCombined regimen of photodynamic therapy mediated by Gallium phthalocyanine chloride and Metformin enhances anti-melanoma efficacyMetformin: A candidate for the treatment of gynecological tumors based on drug repositioning.Metformin for cancer and aging prevention: is it a time to make the long story short?High efficacy of intravesical treatment of metformin on bladder cancer in preclinical model.Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.Metformin blocks progression of obesity-activated thyroid cancer in a mouse model.Metformin therapy associated with survival benefit in lung cancer patients with diabeteslncRNA NBR2 modulates cancer cell sensitivity to phenformin through GLUT1.Metabolic heterogeneity signature of primary treatment-naïve prostate cancer.Increased efficacy of metformin corresponds to differential metabolic effects in the ovarian tumors from obese versus lean mice.Senescence-associated secretory phenotype contributes to pathological angiogenesis in retinopathy.
P2860
Q28307873-AF8A0C9B-4FDF-4FD2-BDB8-DAEC6DE7473EQ33648824-181B2732-26A0-4565-940C-72EA49C873DCQ33766770-DC11A3A4-E401-4752-9C56-DE0CA8D69C4FQ33829205-4B823B90-0D86-4C80-8779-92C9EA4453E2Q34104019-CF165510-558F-4A86-8E4B-9625DE5A0E72Q34391710-7A7A5843-F50E-47E8-9A8B-5E287959B4B9Q34654807-4A605ABB-6BEC-4E71-AFD6-DA6821F66CC5Q36189078-A8D916A5-2559-4E86-883B-90EE44417E31Q36292001-496FBB92-B72C-4B2D-92E5-80126023A745Q36302221-9E3D8381-236B-4E6A-BCCD-DD9714EBB49DQ36524748-AEA69A18-E505-4405-BF4B-B056C0927027Q36545393-C598F3A0-79A7-4AB4-BCFC-3AC3FD63F6D2Q36962520-1FFD6C8C-C1EB-4CDF-B96D-773190187247Q37274957-95C237EC-00A4-47CF-BF04-7286B40DAB8CQ37376404-81272C5B-2D35-4592-8E01-7973DB2B5C3DQ37376577-B508AC40-00F6-475D-B2D8-5E8CEE3764FAQ38735613-A9F7AFE7-3359-4F81-85B9-1B36EB2221ABQ38810786-3FF479F9-06FD-47E0-9548-E376A7DA5C10Q49194546-99A9C647-FC11-4A21-9BC6-14F18BC63272Q51353487-5A1723EC-0672-41E7-A499-12D5B2A36F1E
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Metformin, aging and cancer.
@en
Metformin, aging and cancer.
@nl
type
label
Metformin, aging and cancer.
@en
Metformin, aging and cancer.
@nl
prefLabel
Metformin, aging and cancer.
@en
Metformin, aging and cancer.
@nl
P2860
P356
P1433
P1476
Metformin, aging and cancer
@en
P2093
Michael Pollak
Olga Moiseeva
P2860
P304
P356
10.18632/AGING.100556
P577
2013-05-01T00:00:00Z